Refresh

Aurobindo Pharma Ltd. - Research Center

524804 AUROPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

12,792.28 11,287.14 15,823.68 13,266.48 12,257.89
Expenses

Material consumed

7,009.99 5,981.37 7,425.56 6,692.42 6,362.95

Manufacturing expenses

613.92 477.99 512.34 520.30 505.96

Personnel expenses

1,641.88 1,600.04 1,735.42 1,561.47 1,362.77

Selling expenses

- - - - -

Adminstrative expenses

1,795.57 1,754.34 2,030.53 1,806.54 1,616.92

Expenses capitalised

- - - - -

Cost of sales

11,061.36 9,813.74 11,703.85 10,580.73 9,848.60

Operating profit

1,730.92 1,473.40 4,119.83 2,685.75 2,409.29

Other recurring income

433.76 670.99 589.86 403.37 199.22

Adjusted PBDIT

2,164.68 2,144.39 4,709.69 3,089.12 2,608.51

Financial expenses

114.98 16.94 28.68 240.94 230.86

Depreciation

435.35 415.26 488.00 470.48 413.03

Other write offs

- - - - -

Adjusted PBT

1,614.35 1,712.19 4,193.01 2,377.70 1,964.62

Tax charges

383.94 182.77 1,080.10 504.96 434.89

Adjusted PAT

1,230.41 1,529.42 3,112.91 1,872.74 1,529.73

Non recurring items

5.87 -73.02 -6.42 - -

Other non cash adjustments

- - - - -

Reported net profit

1,236.28 1,456.40 3,106.49 1,872.74 1,529.73

Earnigs before appropriation

17,100.42 16,127.81 14,905.79 12,032.87 10,320.47

Equity dividend

439.45 263.67 234.38 166.12 132.62

Preference dividend

- - - - -

Dividend tax

- - - 9.66 13.86

Retained earnings

16,660.97 15,864.14 14,671.41 11,857.09 10,173.99
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com